HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/2/R402    most recent 00650.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ziegler, T. R. Articles by Gewirtz, A. T. Search for Related Content PubMed PubMed Citation Articles by Ziegler, T. R. Articles by Gewirtz, A. T.

INFLAMMATION AND CYTOKINES

Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome

Departments of ¹Medicine, ²Pathology and Laboratory Medicine, and ³Surgery and ⁴Center for Clinical and Molecular Nutrition, Emory University School of Medicine, Atlanta, Georgia

Submitted 9 September 2007 ; accepted in final form 12 November 2007

Gut barrier dysfunction may occur in short bowel syndrome (SBS). We hypothesized that systemic exposure to flagellin and lipopolysaccharide (LPS) in SBS might regulate specific immune responses. We analyzed serial serum samples obtained from parenteral nutrition (PN)-dependent patients with SBS versus non-SBS control serum. Serum from 23 adult SBS patients was obtained at baseline and 4, 8, 12, 16, 20, and 24 wk in a trial of modified diet with or without growth hormone. Control serum was obtained from 48 healthy adults and 37 adults requiring PN during critical illness. Serum flagellin was detected by an ELISA recognizing an array of gram-negative flagellins, and LPS was detected by limulus assay. Serum flagellin- and LPS-specific immunoglobulin levels (IgM, IgA, and IgG) were determined by ELISA. Serum flagellin and LPS were undetectable in control subjects. In contrast, serum flagellin, LPS, or both were detected in 14 SBS patients (61%) during one or more time points [flagellin alone, 5/23 (22%); LPS alone, 6/23 (26%); or flagellin + LPS, 3/23 (13%)]. Flagellin-specific serum IgM, IgA, and IgG levels were markedly increased in SBS patients compared with both control populations and remained elevated during the 6-mo study period. LPS-specific IgA was significantly higher in SBS patients compared with healthy controls; LPS-specific IgM, IgA, and IgG levels each decreased over time in association with PN weaning. We conclude that adults with PN-dependent SBS are systemically exposed to flagellin and LPS, presumably from the gut lumen. This likely regulates innate and adaptive immune responses to these specific bacterial products.

parenteral nutrition; intestinal barrier function

This article has been cited by other articles:

				J. Tian, L. Hao, P. Chandra, D. P. Jones, I. R. Willams, A. T. Gewirtz, and T. R. Ziegler Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G348 - G355. [Abstract] [Full Text] [PDF]

				Y. Feng, X. Sun, H. Yang, and D. H. Teitelbaum Dissociation of E-cadherin and {beta}-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy J. Physiol., February 1, 2009; 587(3): 641 - 654. [Abstract] [Full Text] [PDF]